Impact of Six‐Month Monitoring Compared to Three‐Month Monitoring of Laboratories During Methotrexate Therapy

Study limitation reported by the research below: “Rare severe toxicity events (e.g., pancytopenia, significant hepatic fibrosis) may be underrepresented given the study's encounter-based design.”